Sectors

MED
Medifast, Inc.
12.21
300 x 12.21
200 x 12.25
bid
ask
+
0.03
0.21%
03:09 PM
timesize
Ytd14.29%
1y-13.00%
12.00
day range
12.28
9.22
52 week range
14.67
Open12.03Prev Close12.18Low12.00High12.28Mkt Cap136.46M
Vol74.35KAvg Vol208.83KEPS-2.33P/EN/AForward P/E56.17
Beta0.65Short Ratio7.68Inst. Own86.16%DividendN/ADiv YieldN/A
Ex Div Date09-18Earning11-0950-d Avg10.99200-d Avg11.151yr Est16.50

MED News

Medifast® Announces the Launch of the Medifast Metabolic Health Institute™
businesswire.com
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Meta

Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?
zacks.com
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?

MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing G

All You Need to Know About Medifast (MED) Rating Upgrade to Buy
zacks.com
All You Need to Know About Medifast (MED) Rating Upgrade to Buy

Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflecte

Great Lakes Advisors LLC Invests $548,000 in Medifast Inc $MED
defenseworld.net
Great Lakes Advisors LLC Invests $548,000 in Medifast Inc $MED

Great Lakes Advisors LLC purchased a new position in shares of Medifast Inc (NYSE: MED) in the undef

Can Medifast's New Compensation Plan Accelerate Coach Growth?
zacks.com
Can Medifast's New Compensation Plan Accelerate Coach Growth?

MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp

Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?
zacks.com
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?

MED's improving coach productivity and client retention point to stabilization, but a shrinking coac

Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?
zacks.com
Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?

Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach bas

MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?
zacks.com
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?

Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations supp

Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
zacks.com
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?

Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue

Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade)
seekingalpha.com
Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade)

Medifast, Inc. has started to report stabilizing sales through improved coach productivity, shown ag

Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves
zacks.com
Medifast Q2 Loss Narrower Than Expected, Coach Productivity Improves

MED tops Q2 earnings expectations despite lower sales, as rising coach productivity helps offset pre

Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript
seekingalpha.com
Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript

Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript

Medifast Q2 Earnings Call Highlights
marketbeat.com
Medifast Q2 Earnings Call Highlights

Medifast NYSE: MED reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year ear

Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates
zacks.com
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates

Medifast (MED) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate

11 Consumer Staples Stocks Moving In Monday's After-Market Session
benzinga.com
11 Consumer Staples Stocks Moving In Monday's After-Market Session

Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market ses

benzinga.com
Medifast Sees Q3 GAAP EPS $(0.65)-$(0.15) vs $(0.62) Est; Sees Sales $60.000M-$80.000M vs $67.700M E

Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees

benzinga.com
Medifast Q2 Adj. EPS $(0.28) Beats $(0.65) Estimate, Sales $76.384M Beat $72.700M Estimate

Medifast (NYSE:MED) reported quarterly losses of $(0.28) per share which beat the analyst consensus

Medifast Announces Second Quarter 2026 Financial Results
businesswire.com
Medifast Announces Second Quarter 2026 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its scie

Medifast Stock to Post Q2 Earnings: What Investors Should Know
zacks.com
Medifast Stock to Post Q2 Earnings: What Investors Should Know

MED's Q2 results are likely to face continued pressure from GLP-1 adoption and a smaller coach base,

Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
zacks.com
Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
businesswire.com
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known fo

Will Medifast's Trilivy Launch Unlock a New Growth Chapter?
zacks.com
Will Medifast's Trilivy Launch Unlock a New Growth Chapter?

Medifast's Trilivy expands beyond weight management with metabolic health support, personalized coac

benzinga.com
Medifast Launches Trilivy, Comprehensive Metabolic Health System; Co. Also Unveils Newly Formulated

The leading health and wellness company unveils an evolutionary transformation from weight loss to o

Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
businesswire.com
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced the launch of Trilivy, a comp

benzinga.com
Medifast Affirms FY2026 GAAP EPS Guidance of $(2.75)-$(1.55) vs $(1.98) Est; Affirms FY2026 Sales Gu

Medifast (NYSE:MED) affirms FY2026 GAAP EPS guidance from $(2.75)-$(1.55) to $(2.75)-$(1.55) vs $(1.

benzinga.com
Medifast Sees Q2 GAAP EPS $(1.00)-$(0.50) vs $(0.43) Est; Sees Sales $60.000M-$80.000M vs $74.700M E

Medifast (NYSE:MED) is looking for Q2 GAAP EPS of $(1.00)-$(0.50) vs $(0.43) analyst estimate. sees

benzinga.com
Medifast Q1 EPS $(0.19) Beats $(0.52) Estimate, Sales $76.044M Beat $69.200M Estimate

Medifast (NYSE:MED) reported quarterly losses of $(0.19) per share which beat the analyst consensus

Earnings Scheduled For May 4, 2026
benzinga.com
Earnings Scheduled For May 4, 2026

12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session

benzinga.com
Medifast Agrees To Nominate Steamboat Capital Partners' Parsa Kiai, Jeff Rose As Independent Directo

Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed,

benzinga.com
Medifast Announces Availability Of OPTAVIA's Comprehensive Metabolic Health System For Reimbursement

 Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is a

benzinga.com
Stephens & Co. Maintains Equal-Weight on Medifast, Lowers Price Target to $12

Stephens & Co. analyst Jim Salera maintains Medifast (NYSE:MED) with a Equal-Weight and lower

Medifast Q4 2025 Earnings Call Transcript
benzinga.com
Medifast Q4 2025 Earnings Call Transcript

Earnings Scheduled For February 17, 2026
benzinga.com
Earnings Scheduled For February 17, 2026

What to Expect from Medifast's Earnings
benzinga.com
What to Expect from Medifast's Earnings

benzinga.com
Medifast Appoints Nicholas Johnson President, Effective Immediately; CEO Dan Chard To Step Down In J

Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide conti

Earnings Scheduled For November 3, 2025
benzinga.com
Earnings Scheduled For November 3, 2025

benzinga.com
Earnings Outlook For Medifast

benzinga.com
UPDATE: Medifast Q2 EPS $0.22 Beats $(0.22) Estimate, Sales $105.600M Beat $96.100M Estimate

Medifast (NYSE:MED) reported quarterly earnings of $0.22 per share which beat the analyst consensus

benzinga.com
Medifast Q3 expected to be more than $(0.60) vs $(0.30) Est; Sees Q3 Sales $70.000M-$90.000M vs $93.

Medifast (NYSE:MED) Q3 expected to be more than $(0.60) vs $(0.30) Est. sees Q3 sales of $70.000 mi

benzinga.com
Earnings Scheduled For August 4, 2025

benzinga.com
Is Medifast Gaining or Losing Market Support?

benzinga.com
Medifast Q2 expected to be more than $(0.55) vs $(0.08) Est; Sees Q2 Sales $85.000M-$105.000M vs $1

Medifast (NYSE:MED) Q2 expected to be more than $(0.55) vs $(0.08) Est. sees Q2 sales of $85.000 mi

benzinga.com
Medifast Q1 EPS $(0.07) Beats $(0.27) Estimate, Sales $115.73M Beat $110.10M Estimate

Medifast (NYSE:MED) reported quarterly losses of $(0.07) per share which beat the analyst consensus

benzinga.com
Earnings Scheduled For April 28, 2025

benzinga.com
Uncovering Potential: Medifast's Earnings Preview

benzinga.com
How Is The Market Feeling About Medifast?

benzinga.com
DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $16.5

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers t

Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday?
benzinga.com
Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday?

All three major U.S. indices are red in Wednesday's midday trading as investors weighed Presiden

benzinga.com
Medifast Q1 expected to be $0 to $(0.50) vs $(0.19) Est; Sees Q1 Sales $100.000M-$120.000M vs $130

Medifast (NYSE:MED) Q1 expected to be more than $(0.50) vs $(0.19) Est. sees Q1 sales of $100.000 m